Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Center for Universal Access and Disability Support (CUADS) produces 22 graduates
2016-04-26

Description: Lutho Xintolo and mom Tags: Lutho Xintolo and mom

Lutho Xintolo (right) is one of the Centre for Universal Access and Disability Support 2016 graduates. She is currently pursuing her Honours in Psychology.
Photo: Supplied

Once again, the University of the Free State (UFS) hosted a successful series of graduations from 12-15 April 2016 where 3681 students were conferred qualifications at the Bloemfontein Campus. Among those graduating were 22 students who are affiliated with the university’s Center for Universal Access and Disability Support (CUADS).

Some of these students included Zingisa Ngwenya, who is currently busy with her second degree; Grant Lombaard, Zanele Morerwa, and Lutho Xintolo, all of whom are pursuing their Honours degrees. Louzanne Coetzee, a visually-impaired international champion athlete, was awarded a Communication: Corporate Marketing Honours degree this autumn. “We have five athletes and a cyclist with disabilities, amongst our students who are of world-class standard,” said Martie Miranda, Head of the Center.

The Center assists students to gain access to study courses, buildings, and lecture venues, learning material such as Braille, audio, enlarged print, and E-text, computer facilities with assistive technology and software and adapted hardware, and a specialised examination and test venue for alternative test and exam procedures,” Miranda added.

Students with disabilities who enrol with CUADS receive support according to their individual needs from registration through to graduation.  “During this process we identify challenges experienced in their administrative, academic, support, student life, and physical environments, and then address these challenges,” Miranda said.

Support provided by the Center includes amanuenses and extra time during tests and exams according to the student’s specific needs, (as determined through evaluation by the Extra Time Panel), together with Student Counselling and Development, academic tutors provided by the New Academic Tutor programme in collaboration with the UFS Centre for Teaching and Learning, and Sign Language interpreters or lip-speakers as well as real-time captioning.

Students with specific learning difficulties, mobility, visual, or hearing impairments, psychological, or other chronic conditions that might have a disabling effect on them, as well as those with temporary impairments, are fully supported by the CUADS. The Center strives to ensure that students achieve their full potential throughout their journey with our university.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept